Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E21.68 EPS (ttm)6.03 Insider Own0.07% Shs Outstand2.65B Perf Week-1.83%
Market Cap346.73B Forward P/E14.33 EPS next Y9.12 Insider Trans0.17% Shs Float2.64B Perf Month-0.05%
Income16.33B PEG3.35 EPS next Q2.00 Inst Own70.20% Short Float0.63% Perf Quarter-1.34%
Sales81.33B P/S4.26 EPS this Y7.60% Inst Trans0.39% Short Ratio2.26 Perf Half Y-4.25%
Book/sh22.92 P/B5.70 EPS next Y6.02% ROA10.60% Target Price149.35 Perf Year-2.33%
Cash/sh5.76 P/C22.70 EPS next 5Y6.46% ROE26.80% 52W Range121.00 - 148.99 Perf YTD1.29%
Dividend3.80 P/FCF40.16 EPS past 5Y3.10% ROI17.00% 52W High-10.53% Beta0.69
Dividend %2.91% Quick Ratio1.00 Sales past 5Y2.70% Gross Margin66.80% 52W Low10.17% ATR2.11
Employees135100 Current Ratio1.30 Sales Q/Q-1.30% Oper. Margin23.40% RSI (14)57.46 Volatility1.35% 1.45%
OptionableYes Debt/Eq0.48 EPS Q/Q43.40% Profit Margin20.10% Rel Volume1.69 Prev Close130.72
ShortableYes LT Debt/Eq0.46 EarningsOct 15 BMO Payout59.60% Avg Volume7.37M Price133.30
Recom2.30 SMA201.95% SMA502.28% SMA200-0.86% Volume4,692,491 Change1.98%
Oct-11-19Upgrade Bernstein Mkt Perform → Outperform $155
Jul-12-19Resumed Credit Suisse Outperform $156
May-28-19Initiated Goldman Buy
Jan-23-19Reiterated Barclays Equal Weight $137 → $135
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Oct-15-19 11:12AM  Prescription drugs boost drives J&J forecasts higher, shares rise Reuters
11:10AM  J&J (JNJ) Beats on Q3 Earnings as Sales Rise, Ups 2019 View Zacks
11:01AM  Pharma Giant J&J Reports Rising Earnings, Sales And Legal Fees Investor's Business Daily
10:46AM  Dow up 280 points on gains for UnitedHealth, JPMorgan Chase stocks MarketWatch
10:44AM  J&J Says No Legal Reserves Needed Amid Wave of Lawsuits Bloomberg
10:43AM  Initial Q3 Results Are Better-Than-Expected Zacks
10:20AM  For J&J and UnitedHealth, Making Money's Easy for Now Bloomberg
10:16AM  US STOCKS-Wall St rises after upbeat start to earnings season Reuters
10:12AM  Q3 Results Begin: Can We Avoid an Earnings Recession? Zacks
10:00AM  Johnson & Johnson Stock Is Up After Its Earnings Beat Barrons.com
09:54AM  US STOCKS-Wall St headed higher on strong earnings start Reuters
09:46AM  UnitedHealth, J.P. Morgan Chase, Johnson & Johnson earnings beats adding combined 119 points to the Dow MarketWatch
09:45AM  UnitedHealth, Johnson & Johnson share gains lead Dow's 135-point climb MarketWatch
09:41AM  For ESG investors, the newest challenge is separating fact from greenwashing MarketWatch
09:06AM  The Dow Is Rising as Fed Policy, Earnings and Brexit Push Trade Aside Barrons.com
08:48AM  Here's Why You Should Hold on to CONMED (CNMD) Stock for Now Zacks
08:42AM  J&J (JNJ) Beats Q3 Earnings & Sales, Shares Rise Zacks
08:02AM  Dow Jones Futures: Snoozing Stock Market Gets Jolt As 4 Dow Giants Report Investor's Business Daily
07:38AM  J&J boosts full-year outlook but warns of uncertain legal costs Financial Times
07:15AM  UPDATE 2-Prescription drugs boost drives J&J forecasts higher, shares rise Reuters
06:58AM  Johnson & Johnson Earnings, Sales Unexpectedly Rise; JNJ Stock Climbs Investor's Business Daily
06:53AM  Johnson & Johnson shares rise after earnings beat estimates, company raises guidance MarketWatch
06:52AM  Prescription drugs boost drives J&J forecasts higher, shares rise Reuters
06:52AM  J&J bumps up full-year profit view on strength of cancer drugs Reuters
06:43AM  Johnson & Johnson Reports 2019 Third-Quarter Results PR Newswire
06:30AM  Johnson & Johnson to Host Earnings Call ACCESSWIRE
03:07AM  Johnson & Johnson Tops Q3 Profit Forecast, Lifts 2019 Guidance: Pharma Surprises TheStreet.com
02:47AM  J&J Earnings, Revenue Beat in Q3 Investing.com
Oct-14-19 07:04PM  Johnson & Johnson's (JNJ) Legal Problems Continue to Worry Investors Zacks
05:09PM  J&J is swamped by opioid fears and lawsuits, but Wall Street isn't worried Yahoo Finance
04:56PM  Bank earnings What to know in markets Tuesday Yahoo Finance
11:45AM  Johnson & Johnson's 3 Most Profitable Lines of Business (JNJ) Investopedia
10:15AM  The Zacks Analyst Blog Highlights: Novartis, J&J, Pfizer, Novo Nordisk and Glaxo Zacks
10:15AM  Major Banks To Flood Wall Street with Earnings Data Zacks
09:58AM  Bank Holiday Ahead of Q3 Earnings, Trade Negotiations Zacks
08:00AM  Johnson & Johnson Is Reporting Its Earnings on Tuesday. Heres What To Expect. Barrons.com
Oct-13-19 04:33PM  The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings Benzinga
10:38AM  Trade war pause, retail sales, bank earnings What to know in the week ahead Yahoo Finance
10:15AM  Congo to start using J&J Ebola vaccine in November Reuters
08:49AM  5 Dividend Stocks With Safe and Growing Payouts When Bonds Cant Do the Trick Barrons.com
Oct-12-19 12:00AM  US law: damages limitation Financial Times
Oct-11-19 06:17PM  Why Johnson & Johnson Stock Can Weather Legal Awards Against It Barrons.com
03:35PM  What to Expect from Q3 Earnings Season with Big Banks Set to Report? Zacks
02:07PM  J&J CEO touts Philadelphia's potential to be the 'Silicon Valley of health care' American City Business Journals
12:03PM  Johnson & Johnson Stock Has Limited Upside InvestorPlace
11:03AM  Pharma Stock Roundup: NVS' New Eye Drug Gets FDA Nod, NVO, GSK, PFE Sign Deals Zacks
10:59AM  Will Q3 Earnings Drive Dow ETF Higher? Zacks
10:44AM  J&J Rises After Analyst Calls Pharma Giant's Shares a Bargain TheStreet.com
09:45AM  Geron Starts Enrollment in Phase III MDS Study on Imetelstat Zacks
08:14AM  The Daily Biotech Pulse: Therapix Extends Merger Deadline, Five Prime Restructures, Gilead-Galapagos Rheumatism Drug Readout Benzinga
Oct-10-19 10:34AM  J&J (JNJ) to Start Q3 Earnings Season for Pharma Sector Zacks
09:29AM  Company News For Oct 10, 2019 Zacks
Oct-09-19 04:23PM  Pharma Giant J&J Dips On $8 Billion Verdict Over Antipsychotic Drug Investor's Business Daily
03:41PM  Johnson & Johnson -- Moody's: Risperdal verdict adds to J&J's litigation risk Moody's
01:57PM  Top Trending: JNJ told to pay $8b to man over breast growth Yahoo Finance Video
01:11PM  US STOCKS-Tech stocks lift Wall St as reports brighten hopes of trade deal Reuters
12:28PM  JNJ Stock Gets A Boost After Settling Opioid Cases But Should You Buy It? Investor's Business Daily
12:15PM  [video]Dow Ends Higher as China Signals Interest in Partial Trade Agreement TheStreet.com
12:05PM  Stocks - Wall Street Gains as Trade Tensions Ease a Little Investing.com
11:42AM  J&J hit by "excessive" $8 bln verdict Reuters Videos
11:15AM  J&J Ordered by Philadelphia Jury to Pay $8B in Risperdal Case Zacks
10:14AM  Dow Jones Jumps 150 Points On China News; Apple, Roku Rally On Analyst Actions Investor's Business Daily
09:59AM  Dow Jones Today: Stocks Bounce As China Seeks Trade War Truce; Apple Gets Price Target Hike Investor's Business Daily
09:28AM  Massive jury award against J&J highlights risks of its legal strategy Reuters
09:12AM  Stocks - J&J Tumbles Premarket; American Outdoor Brands, Exxon Mobil Rise Investing.com
09:08AM  [video]Buy Johnson & Johnson Amid $8 Billion Verdict TheStreet.com
09:05AM  US STOCKS-Wall St eyes strong open as reports fuel trade deal hopes Reuters
09:05AM  Johnson & Johnson Hit With $8B Verdict In Risperdal Lawsuit Benzinga
08:16AM  Johnson & Johnson hit with $8B verdict over drug linked to boy growing breasts CBS News Videos
07:55AM  FirstFT: Todays top stories Financial Times
07:46AM  US STOCKS-Futures gain as reports fuel trade deal hopes Reuters
07:27AM  J&J Unit Ordered to Pay $8 Billion Over Anti-Psychotic Drug Bloomberg
07:10AM  Drugmakers in spotlight as GSK recalls Zantac Reuters Videos
05:46AM  Stocks - Wall Street Opens Higher for First Time in Three Sessions Investing.com
05:43AM  Johnson & Johnson Slides After $8 Billion Verdict in Pennsylvania Risperdal Case TheStreet.com
04:02AM  China Trade Deal Optimism, J&J, Levi Strauss, PG&E - 5 Things You Must Know TheStreet.com
02:52AM  Stocks - U.S. Futures Rise as China Offers to Buy American Agricultural Goods Investing.com
02:15AM  Top 5 Things to Know in the Market on Wednesday Investing.com
01:42AM  PRESS DIGEST- Wall Street Journal - Oct. 9 Reuters
01:37AM  PRESS DIGEST- New York Times business news - Oct. 9 Reuters
Oct-08-19 06:00PM  UPDATE 3-Jury says J&J must pay $8 bln in case over male breast growth linked to Risperdal Reuters
05:45PM  Johnson & Johnson (JNJ) Stock Moves -0.99%: What You Should Know Zacks
03:31PM  [video]Johnson & Johnson Shares Fall After Hours on $8 Billion Jury Award TheStreet.com
02:17PM  Is Johnson & Johnson (JNJ) A Good Stock To Buy According To Hedge Funds? Insider Monkey
12:00PM  Teen beauty spending plunges 20% from last year to a 19-survey low Yahoo Finance
10:30AM  Earnings Preview: Johnson & Johnson (JNJ) Q3 Earnings Expected to Decline Zacks
07:25AM  Johnson & Johnson hit with $8bn court order over antipsychotic drug Financial Times
Oct-07-19 10:55AM  Walmart, Travelers share losses lead Dow's nearly 50-point fall MarketWatch
10:25AM  Theravance Pipeline Strong, Dependence on Yupelri a Concern Zacks
10:05AM  The Zacks Analyst Blog Highlights: J&J, AstraZeneca, Roche, Glaxo and Merck Zacks
08:00AM  Johnson & Johnson Releases Inaugural You Belong: Diversity & Inclusion Impact Review PR Newswire
Oct-05-19 05:10AM  [video]Sackler Family Received $12 Bln to $13 Bln From Opioid Maker Purdue Pharma TheStreet.com
Oct-04-19 02:48PM  Dr. Fred Moll predicts future of robotic surgery industry, explains why he sold Auris Health American City Business Journals
02:15PM  Apple Inc., Merck share gains lead Dow's 279-point rally MarketWatch
11:30AM  Apple Inc., Travelers share gains lead Dow's 200-point climb MarketWatch
11:11AM  Pharma Stock Roundup: JNJ's Opioid Settlement, FDA Updates for AZN, GSK, MRK, RHHBY Zacks
10:31AM  J&J Gets Breakthrough Therapy Tag for Prostate Cancer Drug Zacks
09:45AM  Apple Inc., Visa share gains lead Dow's 138-point climb MarketWatch
07:41AM  Johnson & Johnson commits $500 million over four years to help end HIV, TB epidemics MarketWatch
07:32AM  The Daily Biotech Pulse: Arbutus Halts Hepatitis B Study, Positive Readout For MEI Pharma's Blood Cancer Drug, Ovid Offering Benzinga
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads and tampons under the STAYFREE, CAREFREE, and o.b. brands; wound care products comprising adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. The Pharmaceutical segment offers products in various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular diseases; sterilization and disinfection products to reduce surgical infection; diabetes care products; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, and retail outlets and distributors, as well as distributes directly to wholesalers, hospitals, and health care professionals for prescription use. It has research and collaboration alliance with Morphic Therapeutic. The company was incorporated in 1887 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HEWSON MARILLYN ADirectorJun 11Buy139.683,000419,0403,000Jun 11 05:01 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 11Option Exercise0.0031,4280242,246Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 11Option Exercise0.009,748078,388Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 11Option Exercise0.0013,2730139,434Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 11Option Exercise0.006,722044,546Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 11Option Exercise0.0012,609093,947Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 11Option Exercise0.002,903014,405Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 11Option Exercise0.002,839018,231Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 11Option Exercise0.0022,6240122,430Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 11Option Exercise0.0073,9470414,703Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 11Option Exercise0.007,541021,809Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 11Option Exercise0.0016,968036,138Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 11Option Exercise0.007,275051,687Feb 12 09:14 PM
Stoffels PaulusVice Chair, Exec CommitteeFeb 08Option Exercise0.0012,5710215,138Feb 12 09:15 PM
Taubert Jennifer LEVP, WW Chair, PharmaceuticalsFeb 08Option Exercise0.008,529072,205Feb 12 09:15 PM
Ullmann Michael HExec VP, General CounselFeb 08Option Exercise0.005,3090128,294Feb 12 09:15 PM
Wengel Kathryn EEVP, Chief GSC OfficerFeb 08Option Exercise0.005,882040,197Feb 12 09:15 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 08Option Exercise0.005,044083,371Feb 12 09:15 PM
Wolk Joseph JExec VP, CFOFeb 08Option Exercise0.002,540012,239Feb 12 09:15 PM
Kapusta Ronald AController, CAOFeb 08Option Exercise0.002,484016,125Feb 12 09:15 PM
Duato JoaquinVice Chair, Exec CommitteeFeb 08Option Exercise0.009,0490102,604Feb 12 09:14 PM
Gorsky AlexChairman, CEOFeb 08Option Exercise0.0029,5790352,464Feb 12 09:14 PM
McEvoy AshleyEVP, WW Chair, Medical DevicesFeb 08Option Exercise0.006,599016,092Feb 12 09:14 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 08Option Exercise0.006,787022,179Feb 12 09:14 PM
Sneed Michael EEVP, Global Corp Aff & COOFeb 08Option Exercise0.006,365046,239Feb 12 09:14 PM
PRINCE CHARLESDirectorDec 14Buy134.372,000268,73128,520Dec 17 08:37 AM
MULCAHY ANNE MDirectorDec 14Buy133.76748100,0506,537Dec 17 08:37 AM
PEREZ WILLIAM DDirectorDec 14Buy133.911,000133,9109,122Dec 17 08:37 AM
Kapusta Ronald AController, CAODec 13Sale147.313,643536,63813,641Dec 14 04:33 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Option Exercise96.7341,5634,020,237119,890Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Sale146.6841,5636,096,55278,327Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Option Exercise94.12125,13211,777,919203,459Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Sale146.32125,13218,308,68978,327Dec 06 05:27 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Option Exercise58.3330,9431,804,90570,817Nov 27 06:56 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Sale142.4630,9434,407,98539,874Nov 27 06:56 PM
Gorsky AlexChairman, CEONov 16Option Exercise62.39264,46516,500,026601,024Nov 16 07:44 PM
Gorsky AlexChairman, CEONov 16Sale145.96264,46538,600,968336,559Nov 16 07:44 PM
Kapusta Ronald AController, CAONov 08Sale145.158,4411,225,20017,284Nov 09 05:22 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Option Exercise62.9440,0002,517,526133,555Nov 09 05:20 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Sale144.3640,0005,774,48093,555Nov 09 05:20 PM